new_0222_0458|AVIR|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0458|AVIR|1|Atea Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Atea Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Atea Pharmaceuticals Inc Inventories (Quarterly) (USD)|Atea Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Atea Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Atea Pharmaceuticals Inc Book Value (Quarterly) (USD)|Atea Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Atea Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Atea Pharmaceuticals Inc EV to Revenues|Atea Pharmaceuticals Inc EV to Earnings|Atea Pharmaceuticals Inc EV to Free Cash Flow|Atea Pharmaceuticals Inc EV to Assets (Quarterly)|Atea Pharmaceuticals Inc PS Ratio|Atea Pharmaceuticals Inc PE Ratio|Atea Pharmaceuticals Inc Price to Book Value|Atea Pharmaceuticals Inc PEG Ratio|Atea Pharmaceuticals Inc Debt to Equity Ratio|Atea Pharmaceuticals Inc Dividend Yield|Atea Pharmaceuticals Inc Shareholder Yield (TTM)|Atea Pharmaceuticals Inc Percent of Shares Outstanding Short|Atea Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Atea Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Atea Pharmaceuticals Inc Return on Invested Capital|Atea Pharmaceuticals Inc Quality Ratio Score|Atea Pharmaceuticals Inc Momentum Score|Atea Pharmaceuticals Inc Beta (1Y)|Atea Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Atea Pharmaceuticals Inc Institutional Investor Ownership Percentage|Atea Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Atea Pharmaceuticals Inc Total Employees (Annual)|Atea Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Atea Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Atea Pharmaceuticals Inc Shares Outstanding|Atea Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Atea Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Atea Pharmaceuticals Inc Payout Ratio|Atea Pharmaceuticals Inc Quick Ratio (Quarterly)|Atea Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Atea Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Atea Pharmaceuticals Inc Effective Tax Rate (TTM)|Atea Pharmaceuticals Inc Return on Equity|Atea Pharmaceuticals Inc Net Income (TTM) (USD)|Atea Pharmaceuticals Inc Revenue (TTM) (USD)|Atea Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Atea Pharmaceuticals Inc Revenue (Quarterly) (USD)|Atea Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Atea Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Atea Pharmaceuticals Inc Net Income (Quarterly) (USD)|Atea Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Atea Pharmaceuticals Inc Price (USD)|Atea Pharmaceuticals Inc Total Return Price (USD)|Atea Pharmaceuticals Inc Enterprise Value (USD)|Atea Pharmaceuticals Inc 30-Day Average Daily Volume|Atea Pharmaceuticals Inc 1 Year Price Returns (Daily)|Atea Pharmaceuticals Inc Short Interest|Atea Pharmaceuticals Inc PE Ratio (Forward)|Atea Pharmaceuticals Inc PE Ratio (Forward 1y)|Atea Pharmaceuticals Inc PS Ratio (Forward)|Atea Pharmaceuticals Inc PS Ratio (Forward 1y)|Atea Pharmaceuticals Inc Quarterly EPS Estimates (USD)|Atea Pharmaceuticals Inc Quarterly Revenue Estimates (USD)|Atea Pharmaceuticals Inc Quarterly EPS Surprise|Atea Pharmaceuticals Inc Quarterly Revenue Surprise|Atea Pharmaceuticals Inc Quarterly Actual EPS (USD)|Atea Pharmaceuticals Inc Quarterly Actual Revenue (USD)|Atea Pharmaceuticals Inc Revenue Estimates for Current Fiscal Year (USD)|Atea Pharmaceuticals Inc Revenue Estimates for Next Fiscal Year (USD)|Atea Pharmaceuticals Inc Price Target (USD)|Atea Pharmaceuticals Inc Consensus Recommendation|Atea Pharmaceuticals Inc Price Target Num Estimates|Atea Pharmaceuticals Inc EPS Estimates for Current Fiscal Year (USD)|Atea Pharmaceuticals Inc EPS Estimates for Next Fiscal Year (USD)|Atea Pharmaceuticals Inc Research and Development Expense (Quarterly) (USD)|Atea Pharmaceuticals Inc Reconciled Depreciation (Quarterly) (USD)|Atea Pharmaceuticals Inc Non-Operating Interest Expense (Quarterly) (USD)|Atea Pharmaceuticals Inc Land and Improvements (Quarterly) (USD)|Atea Pharmaceuticals Inc Buildings and Improvements (Quarterly) (USD)|Atea Pharmaceuticals Inc Other Properties (Quarterly) (USD)|Atea Pharmaceuticals Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0458|AVIR|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0458|AVIR|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|daily|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0458|AVIR|5|106.5|106.5||106.5||106.5|106.5|106.5||106.5|106.5||1.4387755102||1.44755244755|91|1.4387755102|1.44|1.44755244755||91|1.4512195122||15.2666666667|106.5|106.5|106.5|||31|30.6666666667|||91.375|182.5|91.375|91.375|31.6666666667||106.5||91|91.375||||91.4|||91||91.375|91.375|91.375|1.4512195122|1.4512195122|1.4512195122|1.45150501672|1.43421052632|15.2666666667|1.45019920319||1.44755244755|1.44755244755|91.3333333333|91.3333333333|91.25|91|91.25|91.25|15.9615384615|16.0740740741|16.0740740741|10.85|16.0740740741|14.9655172414|16.0740740741|91.375|91.375||||122|122||
new_0222_0458|AVIR|6|6|6||6||6|6|6||6|6||98||286|3|98|225|286||3|328||30|6|6|6|||2|3|||8|2|8|8|12||6||3|8||||5|||3||8|8|8|328|328|328|299|76|30|251||286|286|9|9|4|3|4|4|26|27|27|40|27|29|27|8|8||||3|3||
new_0222_0458|AVIR|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0458|AVIR|201909||||||||||||||||||||||||||||||||||47.2925||-0.0768|1.358||||||-0.0768|||||||||-3.632|-3.632|0.137||||||||||||||||||||||||2.411|0.004|||||||
new_0222_0458|AVIR|201912|21.91|21.661||0.041||71.644|2.435|69.209||-49.571|-54.213|||||||||||||||0.548|0.01|||||||47.2925||-0.0984|1.26|||79.2419|||-0.0984|||||||||-4.655|-4.655|0.094||||||||||||||||||||||||3.489|0.004||||0.005|0.024||
new_0222_0458|AVIR|202003||||||||||||||||||||||||||||||||||47.2925||-0.0843|1.224||||||-0.0843|||||||||-3.988|-3.988|0.057||||||||||||||||||||||||2.821|0.004|||||||
new_0222_0458|AVIR|202006|118.45|115.792||0.039||7.127|7.058|0.069||112.618|-68.194|||||||||||||||3.86|0.059|||||||47.2925||-0.2113|2.248|||79.2419|||-0.2113||||-22.268|||||-9.993|-9.993|0.01||||||||||||||||||||||||7.755|0.004||||0.005|0.03||
new_0222_0458|AVIR|202009|108.413|105.383||0.049||186.617|10.816|175.801||-76.511|-85.816|||||||||||||2.5854||4.476|0.01||||||22.1124|79.2419|19|-0.2224|4.028|80.7419||79.2419|||-0.2224||||-36.258|||||-17.622|-17.622|0.007|30.34|30.34|2344.3262|||2135996|||||-1.81||3.8674||-1.74||75|225|52.5|1.3333|2|3.74|0.72|13.601|0.005||||0.005|0.045|33.32|
new_0222_0458|AVIR|202012|863.477|850.117||0.048||315.831|315.795|0.036||547.801|-65.16||||8.7422|3.0037|||6.2873|||||2.9187|5.815|0.06|0.082|||||||82.4369|39|0.2506|14.14|82.4369||82.4369||2.7104|0.2506||||-10.947|||48.633||20.656|20.656|0.009|41.78|41.78|2594.0967|382401.4333||2406079|171.7786||13.6926|15.7847|0.247|45|960.7287|8.0733|2.62|48.633|146.6667|2458.7533|63|1.3333|2|1.4022|22.344|13.846|0.006||||0.005|0.05|73|75.36
new_0222_0458|AVIR|202103|840.145|833.751||0.041||254.391|254.278|0.113||586.258|-34.447||||15.0323|5.0857||393.6054|8.7146|||||3.7571||3.792|0.083|||||||89.0991||0.34|8.759|82.7369||82.7369||3.2789|0.34||||23.754|||65.985||30.713|30.713|0.058|61.75|61.75|4275.2526|357170||3108488|253.8854||20.311|23.4144|-0.0542|31.6115|727.1906|108.7377|0.34|65.985|251.446|3122.4702|72|1.5|3|0.2211|16.7637|26.571|0.007||||||24.71|20.42
new_0222_0458|AVIR|202106|871.11|816.46||0.033||273.682|273.653|0.029||597.861|-32.908||||3.4985|1.1033||55.3344|2.974|||||10.4927|50|17.901|0.083|||||||88.0914||0.02|11.901|82.7769||82.7769||3.1663|0.02||||35.286|||60.391||8.739|1.539|0.052|21.48|21.48|961.5878|1631483.4||8685523|88.3151||7.0687|8.1487|0.0045|58|346.4286|4.1224|0.02|60.391|293.7507|2621.4739|57|1.5|3|0.8565|12.0592|39.803|0.008||||||25.04|29.72
new_0222_0458|AVIR|202109|842.946|839.66||0.026||262.052|262.052|||581.452|-61.102||9.97|83.838|6.7504|2.4564|14.4428|129.5797|5.0075|||||7.7919||34.192|0.083|4.2732||1|-4.4349|5.5243||82.8156|56|-0.34|11.939|83.0471||83.0471||3.2042|-0.34|||5.5243|24.714|207.82||32.811||-22.094|-28.194|0.053|35.06|35.06|2071.9713|1611427.3|-75.7203|6470931|144.1493||11.5753|13.3439|-0.0525|53.4637|-547.2492|-38.6294|-0.34|32.811|287.8252|2654.9742|65|1.4|4|0.7533|14.305|43.019|0.007||||||11.64|8.09
new_0222_0458|AVIR|202112|||||||||||||-0.4654||-0.3151||3.6828|33.0417|1.2777|||||3.1329||||||1|-6.7383||||||||||||||||||||||||8.94|8.94|-96.7219|2088898.2|-78.6022|2603554|42.4623|5.214|17.1447|14.4693|0.5198|85.7267|||||259.0303|218.1996|17|2.2|4|0.4523|-0.4115||||||||7.14|5.92
new_0222_0458|AVIR|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.565|5||||||||||||||||||||
new_0222_0458|AVIR|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.605|||||||||||||||||||||
new_0222_0458|AVIR|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.635|||||||||||||||||||||
new_0222_0458|AVIR|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.51|||||||||||||||||||||